Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States
Ann Intern Med
.
2022 Dec;175(12):1169-1771.
doi: 10.7326/M22-2274.
Epub 2022 Oct 4.
Authors
Kristin Goddard
1
,
Kayla E Hanson
2
,
Ned Lewis
1
,
Eric Weintraub
3
,
Bruce Fireman
1
,
Nicola P Klein
1
Affiliations
1
Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California.
2
Marshfield Clinic Research Institute, Marshfield, Wisconsin.
3
Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia.
PMID:
36191323
PMCID:
PMC9578536
DOI:
10.7326/M22-2274
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
MeSH terms
Adult
COVID-19 Vaccines
COVID-19*
Child
Humans
Incidence
Myocarditis*
Pericarditis*
United States
Vaccination
Substances
COVID-19 Vaccines
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States